TERM ID="NYU_TERM_1" STRING="B-cell lymphoma" FREQUENCY=1 START=1873 END=1888 LEMMA="B-CELL LYMPHOMA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="B-cell neoplasms" FREQUENCY=1 START=1837 END=1853 LEMMA="B-CELL NEOPLASM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="MCL" FREQUENCY=1 START=231 END=234 LEMMA="MCL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="Median progression-free survival durations" FREQUENCY=1 START=1227 END=1269 LEMMA="MEDIAN PROGRESSION-FREE SURVIVAL DURATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="Objective responses" FREQUENCY=1 START=1776 END=1795 LEMMA="OBJECTIVE RESPONSE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="Once-weekly" FREQUENCY=1 START=1012 END=1023 LEMMA="ONCE-WEEKLY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="Temsirolimus" FREQUENCY=3 START=0 END=12 LEMMA="TEMSIROLIMUS" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_8" STRING="Temsirolimus" FREQUENCY=3 START=77 END=89 LEMMA="TEMSIROLIMUS" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_9" STRING="Temsirolimus" FREQUENCY=3 START=1938 END=1950 LEMMA="TEMSIROLIMUS" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_10" STRING="agents warrants" FREQUENCY=1 START=2002 END=2017 LEMMA="AGENTS WARRANT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="anemia" FREQUENCY=1 START=1528 END=1534 LEMMA="ANEMIA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="anti-tumor activity" FREQUENCY=1 START=149 END=168 LEMMA="ANTI-TUMOR ACTIVITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="asthenia" FREQUENCY=1 START=1553 END=1561 LEMMA="ASTHENIA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="choice group" FREQUENCY=1 START=1396 END=1408 LEMMA="CHOICE GROUP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="choice therapy" FREQUENCY=1 START=1211 END=1225 LEMMA="CHOICE THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="clinical dose" FREQUENCY=1 START=1615 END=1628 LEMMA="CLINICAL DOSE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="clinical dose for temsirolimus monotherapy" FREQUENCY=1 START=1615 END=1657 LEMMA="TEMSIROLIMUS MONOTHERAPY CLINICAL DOSE" LEMMA_FREQUENCY=1 HEAD_TERM="clinical dose" HEAD_LEMMA="CLINICAL DOSE"
TERM ID="NYU_TERM_18" STRING="cyclin D1" FREQUENCY=2 START=362 END=371 LEMMA="CYCLIN D1" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_19" STRING="cyclin D1" FREQUENCY=2 START=469 END=478 LEMMA="CYCLIN D1" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_20" STRING="demonstrated anti-tumor activity" FREQUENCY=1 START=688 END=720 LEMMA="DEMONSTRATED ANTI-TUMOR ACTIVITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="eg" FREQUENCY=2 START=358 END=360 LEMMA="EG" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_22" STRING="eg" FREQUENCY=2 START=1855 END=1857 LEMMA="EG" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_23" STRING="follicular lymphoma" FREQUENCY=1 START=1892 END=1911 LEMMA="FOLLICULAR LYMPHOMA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="hazard ratio" FREQUENCY=1 START=1157 END=1169 LEMMA="HAZARD RATIO" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="improved progression-free survival" FREQUENCY=1 START=1121 END=1155 LEMMA="IMPROVED PROGRESSION-FREE SURVIVAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="intracellular kinase" FREQUENCY=1 START=284 END=304 LEMMA="INTRACELLULAR KINASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="investigation" FREQUENCY=1 START=2026 END=2039 LEMMA="INVESTIGATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="investigator" FREQUENCY=3 START=885 END=898 LEMMA="INVESTIGATOR" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_29" STRING="investigator" FREQUENCY=3 START=1195 END=1208 LEMMA="INVESTIGATOR" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_30" STRING="investigator" FREQUENCY=3 START=1380 END=1393 LEMMA="INVESTIGATOR" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_31" STRING="lymphoid neoplasms" FREQUENCY=1 START=253 END=271 LEMMA="LYMPHOID NEOPLASM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="mRNA translation" FREQUENCY=1 START=323 END=339 LEMMA="MRNA TRANSLATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_33" STRING="mTOR" FREQUENCY=2 START=138 END=142 LEMMA="MAMMALIAN TARGET OF RAPAMYCIN" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_34" STRING="mTOR" FREQUENCY=2 START=273 END=277 LEMMA="MAMMALIAN TARGET OF RAPAMYCIN" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_35" STRING="mTOR inhibition" FREQUENCY=1 START=541 END=556 LEMMA="MTOR INHIBITION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_36" STRING="mammalian target" FREQUENCY=1 START=107 END=123 LEMMA="MAMMALIAN TARGET" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_37" STRING="mammalian target of rapamycin" FREQUENCY=2 START=107 END=136 LEMMA="MAMMALIAN TARGET OF RAPAMYCIN" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_38" STRING="mammalian target of rapamycin" FREQUENCY=2 START=107 END=136 LEMMA="MAMMALIAN TARGET OF RAPAMYCIN" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_39" STRING="mantle cell lymphoma" FREQUENCY=2 START=209 END=229 LEMMA="MANTLE CELL LYMPHOMA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_40" STRING="mantle cell lymphoma" FREQUENCY=2 START=16 END=36 LEMMA="MANTLE CELL LYMPHOMA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_41" STRING="mg" FREQUENCY=2 START=1053 END=1055 LEMMA="MG" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_42" STRING="mg" FREQUENCY=2 START=1083 END=1085 LEMMA="MG" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_43" STRING="monotherapy" FREQUENCY=1 START=1954 END=1965 LEMMA="MONOTHERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_44" STRING="neutropenia" FREQUENCY=1 START=1536 END=1547 LEMMA="NEUTROPENIA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_45" STRING="non-Hodgkin lymphoma" FREQUENCY=1 START=47 END=67 LEMMA="NON-HODGKIN LYMPHOMA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_46" STRING="non-Hodgkin lymphomas" FREQUENCY=1 START=2071 END=2092 LEMMA="NON-HODGKIN LYMPHOMA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_47" STRING="objective response rates" FREQUENCY=1 START=1313 END=1337 LEMMA="OBJECTIVE RESPONSE RATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_48" STRING="oncogenes" FREQUENCY=1 START=389 END=398 LEMMA="ONCOGENE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_49" STRING="overexpression" FREQUENCY=1 START=451 END=465 LEMMA="OVEREXPRESSION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_50" STRING="overexpression of cyclin D1" FREQUENCY=1 START=451 END=478 LEMMA="CYCLIN D1 OVEREXPRESSION" LEMMA_FREQUENCY=1 HEAD_TERM="overexpression" HEAD_LEMMA="OVEREXPRESSION"
TERM ID="NYU_TERM_51" STRING="pathogenesis" FREQUENCY=1 START=1746 END=1758 LEMMA="PATHOGENESI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_52" STRING="pretreated patients" FREQUENCY=1 START=931 END=950 LEMMA="PRETREATED PATIENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_53" STRING="randomized phase III" FREQUENCY=1 START=793 END=813 LEMMA="RANDOMIZED PHASE III" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_54" STRING="rapamycin" FREQUENCY=1 START=127 END=136 LEMMA="RAPAMYCIN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_55" STRING="receiving temsirolimus" FREQUENCY=1 START=1435 END=1457 LEMMA="RECEIVING TEMSIROLIMUS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_56" STRING="refractory mantle cell lymphoma" FREQUENCY=1 START=198 END=229 LEMMA="REFRACTORY MANTLE CELL LYMPHOMA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_57" STRING="response rates" FREQUENCY=1 START=735 END=749 LEMMA="RESPONSE RATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_58" STRING="single-agent temsirolimus" FREQUENCY=1 START=563 END=588 LEMMA="SINGLE-AGENT TEMSIROLIMUS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_59" STRING="temsirolimus" FREQUENCY=1 START=868 END=880 LEMMA="TEMSIROLIMUS" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_60" STRING="temsirolimus monotherapy" FREQUENCY=1 START=1633 END=1657 LEMMA="TEMSIROLIMUS MONOTHERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_61" STRING="three-arm" FREQUENCY=1 START=782 END=791 LEMMA="THREE-ARM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_62" STRING="thrombocytopenia" FREQUENCY=1 START=1510 END=1526 LEMMA="THROMBOCYTOPENIA" LEMMA_FREQUENCY=1
